Cargando…
What Is New on Ovarian Carcinoma: Integrated Morphologic and Molecular Analysis Following the New 2020 World Health Organization Classification of Female Genital Tumors
Ovarian carcinomas represent a heterogeneous group of neoplasms consisting of separate entities with distinct risk factors, precursor lesions, pathogenesis, patterns of spread, molecular profiles, clinical course, response to chemotherapy, and outcomes. The histologic subtype and the related molecul...
Autores principales: | De Leo, Antonio, Santini, Donatella, Ceccarelli, Claudio, Santandrea, Giacomo, Palicelli, Andrea, Acquaviva, Giorgia, Chiarucci, Federico, Rosini, Francesca, Ravegnini, Gloria, Pession, Annalisa, Turchetti, Daniela, Zamagni, Claudio, Perrone, Anna Myriam, De Iaco, Pierandrea, Tallini, Giovanni, de Biase, Dario |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8070731/ https://www.ncbi.nlm.nih.gov/pubmed/33919741 http://dx.doi.org/10.3390/diagnostics11040697 |
Ejemplares similares
-
ARID1A and CTNNB1/β-Catenin Molecular Status Affects the Clinicopathologic Features and Prognosis of Endometrial Carcinoma: Implications for an Improved Surrogate Molecular Classification
por: De Leo, Antonio, et al.
Publicado: (2021) -
Relevance of ARID1A Mutations in Endometrial Carcinomas
por: De Leo, Antonio, et al.
Publicado: (2022) -
Integrated clinicopathologic and molecular analysis of endometrial carcinoma: Prognostic impact of the new ESGO-ESTRO-ESP endometrial cancer risk classification and proposal of histopathologic algorithm for its implementation in clinical practice
por: de Biase, Dario, et al.
Publicado: (2023) -
BRCA-Associated Ovarian Cancer: From Molecular Genetics to Risk Management
por: Girolimetti, Giulia, et al.
Publicado: (2014) -
Identification of miR-499a-5p as a Potential Novel Biomarker for Risk Stratification in Endometrial Cancer
por: Ravegnini, Gloria, et al.
Publicado: (2021)